Open-Angle Glaucoma Drugs Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Open-Angle Glaucoma Drugs Market is segmented By Types of Open-Angle Glaucoma (Primary Open-Angle Glaucoma, Secondary Open-Angle Glaucoma), By Risk Factors (General Factors, Ocular Factors, Non-ocular Factors, Ocular Hypertension), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Competitive overview of Open-Angle Glaucoma Drugs Market
The major players operating in the Open-Angle Glaucoma Drugs Market include Aerie Pharmaceuticals, Alcon Research, Allergan, Bausch and Lomb, Chong Kun Dang Pharmaceutical, D.Western Therapeutics Institute (DWTI)/Kowa LTD., Envisia Therapeutics, Laboratorios Sophia S.A de C.V., Merck Sharp & Dohme Corp., Nicox Ophthalmics, Novartis/Alcon Research, Ocuphire Pharma, Ono Pharmaceutical, Peregrine Ophthalmic, Perrigo Company, Santen Inc., Santen Pharmaceutical, Sun Pharma Advanced Research Company Limited (SPARC), and Sylentis.
Open-Angle Glaucoma Drugs Market Leaders
- Aerie Pharmaceuticals
- Alcon Research
- Allergan
- Bausch and Lomb
- Chong Kun Dang Pharmaceutical
Open-Angle Glaucoma Drugs Market - Competitive Rivalry, 2023
Open-Angle Glaucoma Drugs Market
(Dominated by major players)
(Highly competitive with lots of players.)